Home / Market News / $LQDA
benzinga Corporate Catalyst Impact 65/100 ● positive

Needham Maintains Buy on Liquidia, Raises Price Target to $110

Aug 12, 2026, 7:19 PM UTC · Primary ticker $LQDA

Needham analyst Serge Belanger reiterated a Buy rating on Liquidia and significantly increased the price target from $70 to $110. This upward revision by a prominent analyst suggests increased confidence in the company's future prospects, likely driven by recent developments or re-evaluation of its market potential.

Needham analyst Serge Belanger maintained a 'Buy' rating on Liquidia and raised the price target from $70 to $110. This substantial increase in the price target signals a strong positive outlook from a reputable financial institution, likely based on new information, successful clinical trials, or a re-evaluation of the company's market position and product pipeline. This news is primarily positive for Liquidia shareholders, as it could lead to increased investor confidence and potentially drive up the stock price in the short term. The long-term implications depend on whether the company can meet the expectations implied by this higher valuation. A key opportunity for traders is to capitalize on the potential upward momentum following this analyst upgrade, though the risk lies in whether the market has already priced in such expectations or if future company performance fails to justify the new target.

$LQDA positive Analyst price target increase
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.